Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Fase III-studies naar gantenerumab bij vroege ziekte van Alzheimer
mrt 2024 | Dementie